Patents
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
10/2013
10/01/2013US8546403 Compounds that modulate intracellular calcium
09/2013
09/26/2013WO2013139206A1 3-oxo-3,4-dihydro-2-pyrazine-formamide derivative, pharmaceutical composition of same, method for preparing same, and use thereof
09/26/2013US20130252974 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as urotensin ii receptor antagonists
09/26/2013DE10321565B4 Verfahren zur Herstellung von Alkyldihydro-1,4-diazinen und Alkyl-1,4-diazinen A process for preparing Alkyldihydro-1,4-diazines, and alkyl-1,4-diazines
09/25/2013EP2640507A1 Acid gas absorbent composition
09/24/2013US8541579 Substituted diketopiperazines as oxytocin antagonists
09/24/2013US8541578 Process for the production of n-(2,6-dimethyl-phenyl)-2-piperazin-1-yl-acetamide
09/24/2013US8541572 Compounds for the treatment of inflammatory disorders
09/24/2013US8541415 Targeting an HIV-1 nef-host cell kinase complex
09/24/2013US8541406 Thiadiazole derivatives for the treatment of neurodegenerative diseases
09/19/2013WO2013137832A1 Myostatin inhibitors
09/19/2013WO2013137479A1 Decahydroquinoxaline derivatives and analogs thereof
09/19/2013US20130245264 Pyrazino[2,3-d]isoxazole derivative
09/19/2013US20130245034 Inhibitors Of Histone Deacetylase
09/19/2013US20130244995 Calcium-sensing receptor-active compounds
09/18/2013EP2639235A1 Pyrazino[2,3-d]isooxazole derivative
09/18/2013EP2639216A1 Halogenated indenones and method for producing optically active indanones or optically active indanols by using same
09/18/2013EP2638181A1 Non metal tanning
09/18/2013EP2638036A1 Compound for increasing kinase active and application thereof
09/18/2013EP2638019A1 Herbicidal compounds
09/18/2013CN103304496A Method for synthesizing phenazine-1-carboxylic acid
09/18/2013CN103304495A Preparation method and applications of olaquindox metabolite hapten
09/18/2013CN103304494A Indene (1,2-b) quinoxaline-11-ketoxime derivatives and preparation method as well as application thereof
09/18/2013CN103304428A Amine-based compound, organic light-emitting diode including the same, and organic light-emitting apparatus including the amine-based compound
09/17/2013US8536184 Nitrogenous heterocyclic compounds and process for making nitrogenous heterocyclic compounds and intermediates thereof
09/17/2013US8536178 Pharmaceutical composition for preventing or treating diseases associated with beta-amyloid accumulation containing morpholin or piperazine based compounds having SO3H or COOH as active ingredient
09/17/2013CA2570903C N-hydroxyamide derivatives and use thereof
09/12/2013WO2013134061A1 Phenicol antibacterials
09/12/2013WO2013131978A1 Process for the preparation of intermediates useful in the preparation of a viral protease inhibitor
09/12/2013WO2013084214A3 Pyrazinoic acid prodrugs activated by esterases of mycobacteria
09/12/2013US20130237529 Compound that can inhibit ubc13-uev interactions, pharmaceutical compositions and therapeutic uses
09/12/2013US20130237528 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
09/11/2013CN103298786A Salts of arylsulfonamide ccr3 antagonists
09/11/2013CN103288764A Quinhydroxy ketone glycine ester hydrochloride and preparation method thereof
09/11/2013CN103288763A Industrial production method of 2,6-dichloropyrazine
09/11/2013CN103288752A Cinnamic amide derivatives, their preparation methods and their application in preparation of bleeding stopping and stasis dissolving medicines
09/11/2013CN102329272B Method for preparing quinocetone
09/10/2013US8530673 Tetrathiafulvalene derivative, and organic film and organic transistor using the same
09/10/2013US8530658 Carbazole derivative with heteroaromatic ring, and light-emitting element, light-emitting device, and electronic device using carbazole derivative with heteroaromatic ring
09/10/2013US8530469 Therapeutic combinations of hydroxybenzamide derivatives as inhibitors of HSP90
09/10/2013US8529796 Charge transport compositions and electronic devices made with such compositions
09/06/2013WO2013059433A3 Hybrid diazeniumdiolated compounds, pharmaceutical compositions, and method of treating cancer
09/05/2013US20130231479 Aryloxyurea compound and pest control agent
09/05/2013US20130231351 Sir2 regulation
09/05/2013US20130231342 Arylcyclopropylamine based demethylase inhibitors of lsd1 and their medical use
09/05/2013US20130231319 Bridged Spiro[2.4]heptane Ester Derivatives
09/04/2013EP2632465A1 Inhibitors of the renal outer medullary potassium channel
09/04/2013CN203170326U Reaction kettle for preparing acetylpyrazine
09/04/2013CN103275021A N-dichloracetyl-6, 7-dichloro-1, 2, 3, 4-tetrahydro quinoxaline and preparation method thereof
09/04/2013CN102225913B Rheinic acid derivatives and treatment application thereof
09/04/2013CN102066342B Quinoxalinedione derivatives
09/04/2013CN101374820B Piperazine compounds with a herbicidal action
09/03/2013US8524717 Oxidase inhibitors and their use
09/03/2013US8524714 7-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors
09/03/2013US8524711 Amino-derivatives as novel inhibitors of histone deacetylase
09/03/2013CA2572153C Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes
08/2013
08/29/2013US20130225587 Compound for increasing kinase active and application thereof
08/29/2013US20130224882 Assay for the Detection of the Phenylpiperazine Family
08/29/2013DE102012202782A1 Neue Oxidationsfarbstoffvorprodukte Last oxidation dye precursors
08/28/2013EP2631229A1 P2x4 receptor antagonist
08/28/2013EP2630130A1 Method for preparing substituted n-(3-amino-quinoxalin-2-yl)-sulfonamides and their intermediates n-(3-chloro-quinoxalin-2-yl)sulfonamides
08/28/2013EP2630129A1 Quinoxaline derivates
08/28/2013CN103270027A Method for preparing substituted n-3-amino-quinoxalin-<wbr/>2-yl)-sulfonamides and their intermediates n-<wbr/>(3-chloro-quinoxalin-<wbr/>2-yl)sulfonamides
08/28/2013CN103265498A Novel technology for trans-2,6-lupetazin
08/28/2013CN101812026B Method for synthesizing bortezomib
08/27/2013US8519127 Cyclic glycyl-2-allyl proline and its use in treatment of peripheral neuropathy
08/22/2013WO2013121387A1 Anti -malarial agents
08/22/2013US20130217708 Meglumine salt of 6-fluoro-3-hydroxy-2-pyrazine carboxamide
08/22/2013US20130217706 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
08/22/2013US20130217687 Arylsulfonamide ccr3 antagonists
08/22/2013US20130217670 Quinoxaline derivatives
08/22/2013US20130217660 Novel prolylcarboxypeptidase inhibitors
08/21/2013EP2627635A1 Salts of arylsulfonamide ccr3 antagonists
08/21/2013CN103261165A 胰高血糖素受体调节剂 Glucagon receptor modulators
08/21/2013CN103261164A Neprilysin inhibitors
08/21/2013CN102127056B Tubulin inhibitors
08/21/2013CN102036963B Derivatives of quinolines and quinoxalines as protein tyrosine kinase inhibitors
08/21/2013CN101981015B 3-trifluoromethyl-pyrazine-2-carboxylic acid amide derivatives as HDL-cholesterol raising agents
08/20/2013US8513415 Preparation of C-pyrazine-methylamines
08/20/2013US8513268 1H-quinazoline-2,4-diones processes for their production, pharmaceutical compositions, and treatment for epilepsy
08/20/2013US8513261 Tablet and granulated powder containing 6-fluoro-3-hydroxy-2-pyrazinecarboxamide
08/20/2013US8513252 Pyrazole derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
08/20/2013US8513241 3,4-dihydro-2H-pyrazino[1,2-A]indol-1-one derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
08/20/2013CA2736281C Tri-substituted pyrimidine compounds and their use as pde10 inhibitors
08/15/2013US20130211081 Method for stereoselective synthesis of bicyclic heterocyclic compounds
08/15/2013US20130211076 Method for preparing substituted N-(3-amino-quinoxalin-2-yl)-sulfonamides and their intermediates N-(3-chloro-quinoxalin-2-yl)-sulfonamides
08/14/2013CN103249723A Pyrazine derivatives as enac blockers
08/14/2013CN103249720A Oxime compounds as HDL-holesterol raising agents
08/14/2013CN103242250A Preparation method of 2-quinoxaline methylene hydrazino cyanoacetic acid-N1-oxide
08/14/2013CN103242249A Compound capable of identifying dodecylbenzene sulfonic acid ions as well as preparation method and application thereof
08/14/2013CN103242248A Pyrazine semicarbazide compound as well as preparation method and application thereof
08/14/2013CN103242247A Synthesis and refining method of 2, 5-dihydroxymethyl-3, 6-dimethyl pyrazine
08/14/2013CN103242246A Synthetic method of 3-substituted N-methyl piperazine
08/14/2013CN103242210A Mulin acetate containing substituted squaric acid and application thereof
08/14/2013CN103242167A Amine compound, electrophotographic photoconductor, image forming method, image forming apparatus, and process cartridge
08/14/2013CN102276539B Bacteriostatic compound and preparation method thereof
08/14/2013CN101341135B Substituted pyrazinone derivatives for use in MCH-1 mediated diseases
08/14/2013CN101282946B 半胱氨酸蛋白酶抑制剂及它们的治疗应用 Cysteine ​​protease inhibitors and their therapeutic applications
08/13/2013CA2589748C Heterocyclic compounds as ccr2b antagonists
08/08/2013US20130203988 Process for making bortezomib and intermediates for the process
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... 187